- Home
- XNCR vs ATHM Comparison
XNCR vs ATHM Comparison
Compare XNCR & ATHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XNCR | ATHM |
|---|---|---|
| Founded | 1997 | 2008 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.4B |
| IPO Year | 2013 | 2013 |
Fundamental Metrics
Financial Performance| Metric | XNCR | ATHM |
|---|---|---|
| Price | $24.77 | $20.86 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 13 |
| Target Price | ★ $31.42 | $21.40 |
| AVG Volume (30 Days) | ★ 1.0M | 371.3K |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 8.42% |
| EPS Growth | ★ 65.36 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $125,576,000.00 | N/A |
| Revenue This Year | $14.05 | N/A |
| Revenue Next Year | N/A | $1.59 |
| P/E Ratio | ★ N/A | $12.13 |
| Revenue Growth | ★ 13.65 | N/A |
| 52 Week Low | $10.38 | $15.57 |
| 52 Week High | $30.61 | $29.07 |
Technical Indicators
Market Signals| Indicator | XNCR | ATHM |
|---|---|---|
| Relative Strength Index (RSI) | 51.52 | 43.68 |
| Support Level | $23.36 | $20.74 |
| Resistance Level | $30.61 | $22.24 |
| Average True Range (ATR) | 1.03 | 0.52 |
| MACD | -0.09 | -0.01 |
| Stochastic Oscillator | 55.23 | 44.54 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
About ATHM Autohome Inc.
Founded in 2008 as a media content platform, Autohome is the leading online automobile platform in China, ranking first among automotive service platforms in terms of mobile daily active users, according to QuestMobile. Through its two websites, autohome.com.cn and che168.com, Autohome delivers comprehensive, independent, and interactive content and tools to automobile consumers as well as a full suite of services to automakers and dealers. According to iResearch, the company was the largest online automotive advertising and lead-generation service provider in China's online auto platform media advertising market, in terms of media services and lead-generation revenue.